25 completed, 2 terminated, 1 withdrawn. 12 Phase 1, 12 Phase 2, 4 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 12 | Completed 12 |
| Phase 2 | 12 | Completed 11, Terminated 1 |
| Not applicable | 4 | Completed 2, Terminated 1, Withdrawn 1 |
| Phase 3 | 1 | Completed 1 |
Follow Stage III Ovarian Epithelial Cancer: new trials by email Literature Review of Stage III Ovarian Epithelial Cancer trials Research Report on Stage III Ovarian Epithelial Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant management of therapy complications, musculoskeletal complications management/prevention - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission | Not applicable | Withdrawn | Roswell Park Cancer Institute | 2012-05-01 | 2012-07-09 | |
| Vaccine Therapy in Treating Patients With Stage III-IV or Recurrent Ovarian Cancer pUMVC3-hIGFBP-2 multi-epitope plasmid DNA vaccine, laboratory biomarker analysis - Stage III Ovarian Epithelial Cancer, Stage III Ovarian Germ Cell Tumor | Phase 1 | Completed | University of Washington | 25 | 2012-03-06 | 2021-02-25 |
| Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload deferasirox - Iron Overload, Accelerated Phase Chronic Myelogenous Leukemia | Phase 2 | Terminated | City of Hope Medical Center | 1 | 2010-07-01 | 2019-06-18 |
| Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors temsirolimus, vinorelbine ditartrate - Extensive Stage Small Cell Lung Cancer, Hereditary Paraganglioma | Phase 1 | Completed | University of Southern California | 19 | 2010-06-01 | 2016-06-13 |
| Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC) HIPEC Orientation, Consultation with Survivorship Navigator, Questionnaires - Advanced Malignant Mesothelioma, Carcinoma of the Appendix | Not applicable | Completed | Wake Forest University Health Sciences | 10 | 2010-05-01 | 2018-07-03 |
| Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignancies stereotactic radiosurgery, quality-of-life assessment - Fallopian Tube Cancer, Ovarian Sarcoma | Phase 2 | Completed | Case Comprehensive Cancer Center | 50 | 2009-05-01 | 2013-11-28 |
| Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant ondansetron, survey administration, management of therapy complications - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission | Phase 2 | Completed | Fred Hutchinson Cancer Center | 49 | 2008-08-08 | 2017-05-23 |
| Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Recurrent Advanced Ovarian Epithelial or Peritoneal Cavity Cancer gemcitabine hydrochloride, tanespimycin - Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer | Phase 2 | Completed | National Cancer Institute (NCI) | 29 | 2007-10-01 | 2014-05-20 |
| Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors paclitaxel, carboplatin, temsirolimus - Ovarian Sarcoma, Ovarian Stromal Cancer | Phase 1 | Completed | National Cancer Institute (NCI) | 38 | 2007-02-01 | 2014-06-19 |
| Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma ziv-aflibercept - Fallopian Tube Cancer, Female Reproductive Cancer | Phase 2 | Completed | National Cancer Institute (NCI) | 63 | 2006-09-01 | 2015-12-07 |
| Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant lithium carbonate, laboratory biomarker analysis - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission | Not applicable | Completed | Fred Hutchinson Cancer Center | 20 | 2006-06-01 | 2017-03-07 |
| Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy sargramostim, paclitaxel albumin-stabilized nanoparticle formulation, laboratory biomarker analysis - Brenner Tumor, Fallopian Tube Cancer | Phase 2 | Completed | University of Washington | 21 | 2006-05-01 | 2017-08-28 |
| Ixabepilone and Liposomal Doxorubicin in Advanced Ovarian Cancer ixabepilone, pegylated liposomal doxorubicin hydrochloride - Fallopian Tube Cancer, Female Reproductive Cancer | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 45 | 2006-01-01 | 2016-03-10 |
| 3-AP and Cisplatin in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer triapine, cisplatin, laboratory biomarker analysis - Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer | Phase 2 | Completed | National Cancer Institute (NCI) | 48 | 2005-07-01 | 2013-01-24 |
| Denileukin Diftitox Used in Treating Patients With Advanced Refractory Ovarian Cancer, Primary Peritoneal Carcinoma, or Epithelial Fallopian Tube Cancer denileukin diftitox, intraperitoneal administration, laboratory biomarker analysis - Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma | Phase 1 | Completed | University of Washington | 11 | 2005-04-01 | 2019-05-14 |
| EF5 in Finding Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Cervical, Endometrial, or Ovarian Epithelial Cancer EF5 - Primary Peritoneal Cavity Cancer, Stage I Endometrial Carcinoma | Phase 2 | Completed | National Cancer Institute (NCI) | 60 | 2005-02-01 | 2013-01-16 |
| Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors alvespimycin hydrochloride, laboratory biomarker analysis, pharmacological study - Male Breast Cancer, Recurrent Adenoid Cystic Carcinoma of the Oral Cavity | Phase 1 | Completed | National Cancer Institute (NCI) | 30 | 2004-07-01 | 2013-04-10 |
| Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer adjuvant therapy, paclitaxel, carboplatin - Brenner Tumor, Fallopian Tube Cancer | Phase 1 | Completed | National Cancer Institute (NCI) | 113 | 2004-06-01 | 2019-07-22 |
| EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer EF5, motexafin lutetium, pharmacological study - Advanced Adult Primary Liver Cancer, Carcinoma of the Appendix | Not applicable | Terminated | National Cancer Institute (NCI) | 30 | 2004-05-01 | 2013-01-16 |
| Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer) carboplatin, paclitaxel, docetaxel - Brenner Tumor, Fallopian Tube Cancer | Phase 1 | Completed | National Cancer Institute (NCI) | 40 | 2004-05-01 | 2019-07-22 |
Showing 20 of 28. Sign in to see all of them.
Carcinoma, Ovarian Epithelial (28) · Fallopian Tube Neoplasms (12) · Breast Neoplasms (10) · Testicular Neoplasms (6) · Brenner Tumor (5) · Burkitt Lymphoma (5) · Congenital Abnormalities (5) · Endometrial Neoplasms (5) · Hodgkin Disease (5) · Leukemia, Lymphocytic, Chronic, B-Cell (5) · Leukemia, Myeloid, Acute (5) · Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative (5) · Lymphoma, Follicular (5) · Lymphoma, Large B-Cell, Diffuse (5) · Lymphoma, Large-Cell, Immunoblastic (5)
Adnexal Diseases (28) · Carcinoma (28) · Endocrine Gland Neoplasms (28) · Endocrine System Diseases (28) · Female Urogenital Diseases (28) · Female Urogenital Diseases and Pregnancy Complications (28) · Genital Diseases (28) · Genital Diseases, Female (28) · Genital Neoplasms, Female (28) · Gonadal Disorders (28) · Neoplasms by Histologic Type (28) · Neoplasms by Site (28) · Neoplasms, Glandular and Epithelial (28) · Ovarian Diseases (28) · Urogenital Diseases (28)
Taxes (6) · Paclitaxel (5) · Carboplatin (4) · Cisplatin (3) · Bevacizumab (2) · Flow Cytometry (2) · Granulocyte-Macrophage Colony-Stimulating Factor (2) · Immunologic Techniques (2) · Sirolimus (2) · sargramostim (2) · temsirolimus (2) · 130-nm albumin-bound paclitaxel (1) · 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (1) · 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (1) · Albumin-Bound Paclitaxel (1)
National Cancer Institute (NCI) (17) · University of Washington (4) · Fred Hutchinson Cancer Center (2) · Case Comprehensive Cancer Center (1) · City of Hope Medical Center (1) · Roswell Park Cancer Institute (1) · University of Southern California (1) · Wake Forest University Health Sciences (1)
United States (26) · Canada (2) · Japan (1)
Amit Oza (2) · Agustin Garcia (1) · Barbara Goff (1) · Christina Chu (1) · David Alberts (1) · David Solit (1) · Deborah Armstrong (1) · Ellen Chuang (1) · Ewa Carrier (1) · Jean Hurteau (1) · Joan Walker (1) · Leona Holmberg (1) · Lupe Salazar (1) · Lydia Usha (1) · Mark Morgan (1)
PMID 18974373, PMID 20357034, PMID 20837357, PMID 22541066, PMID 28817727, PMID 36326756, PMID 39362046
U10CA027469 (5), N01CM62204 (2), N01CM17101 (1), N01CM62201 (1), N01CM62203 (1), N01CM62205 (1), N01CM62209 (1), P01CA087971 (1), P30CA013330 (1), P30CA015083 (1), P30CA015704 (1), R01CA093891 (1), R21CA099346 (1), U01CA069856 (1), U01CA076576 (1)